Pfizer Alum’s China Startup Is Said to Select Banks for IPO

The Shanghai-based biopharmaceutical company … Wuxi Biologics Cayman Inc. has risen 53 percent from the offer price in its June IPO, making it the best performer this year among Hong Kong new listings that raised more than $500 million, according …
( read original story …)


Related Post